Epidemiology and outcome of hepatitis C relapse in transplant recipients

Transplant Proc. Jul-Aug 2011;43(6):2457-8. doi: 10.1016/j.transproceed.2011.06.016.

Abstract

Hepatitis C virus (HCV)-related end-stage liver disease represents the primary indication for liver transplantation in Western countries, but is associated with poor posttransplantation outcomes and a rapid progression of HCV-related disease. This article reviews the risk factors underlying this association and presents the current strategies used to manage HCV infections in transplant recipients.

Publication types

  • Review

MeSH terms

  • Antiviral Agents / therapeutic use*
  • End Stage Liver Disease / diagnosis
  • End Stage Liver Disease / epidemiology
  • End Stage Liver Disease / surgery*
  • End Stage Liver Disease / virology
  • Hepatitis C / complications
  • Hepatitis C / diagnosis
  • Hepatitis C / drug therapy*
  • Hepatitis C / epidemiology
  • Humans
  • Liver Transplantation* / adverse effects
  • Recurrence
  • Risk Assessment
  • Risk Factors
  • Treatment Outcome

Substances

  • Antiviral Agents